M.D.C. Holdings Analyst Ratings
M.D.C. Holdings Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/03/2023 | 16.62% | Raymond James | $55 → $60 | Maintains | Outperform |
| 07/31/2023 | -0.87% | Wedbush | $28 → $51 | Maintains | Neutral |
| 07/14/2023 | 6.9% | Raymond James | → $55 | Upgrades | Market Perform → Outperform |
| 06/14/2023 | — | Seaport Global | Initiates Coverage On | → Neutral | |
| 05/03/2023 | -45.58% | Wedbush | → $28 | Reiterates | → Neutral |
| 03/06/2023 | -46.55% | JP Morgan | $30.5 → $27.5 | Maintains | Underweight |
| 11/22/2022 | -45.58% | JP Morgan | $27 → $28 | Downgrades | Neutral → Underweight |
| 11/03/2022 | -47.52% | JP Morgan | $31.5 → $27 | Maintains | Neutral |
| 10/21/2022 | — | Raymond James | Downgrades | Strong Buy → Market Perform | |
| 08/01/2022 | -14.48% | Raymond James | $77 → $44 | Maintains | Strong Buy |
| 07/12/2022 | -26.14% | JP Morgan | $40.5 → $38 | Maintains | Neutral |
| 06/17/2022 | -47.52% | Wells Fargo | → $27 | Downgrades | Equal-Weight → Underweight |
| 04/13/2022 | -24.2% | JP Morgan | $49 → $39 | Maintains | Neutral |
| 03/10/2022 | -4.76% | JP Morgan | $66 → $49 | Maintains | Neutral |
| 11/08/2021 | 49.66% | Raymond James | $79 → $77 | Maintains | Strong Buy |
| 10/14/2021 | 28.28% | JP Morgan | → $66 | Downgrades | Overweight → Neutral |
| 08/19/2021 | 53.55% | Raymond James | $80 → $79 | Maintains | Strong Buy |
| 04/16/2021 | 26.34% | Wells Fargo | → $65 | Initiates Coverage On | → Equal-Weight |
| 03/16/2021 | — | Wolfe Research | Initiates Coverage On | → Peer Perform | |
| 03/12/2021 | 22.45% | B of A Securities | → $63 | Downgrades | Neutral → Underperform |
| 02/02/2021 | 38% | Raymond James | $71 → $71 | Maintains | Strong Buy |
| 01/25/2021 | 38% | Raymond James | $61 → $71 | Maintains | Strong Buy |
| 01/05/2021 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 10/30/2020 | -10.59% | Wells Fargo | → $46 | Upgrades | Underweight → Equal-Weight |
| 10/08/2020 | 30.22% | JP Morgan | → $67 | Upgrades | Neutral → Overweight |
| 09/15/2020 | 10.79% | B of A Securities | → $57 | Upgrades | Neutral → Buy |
| 07/29/2020 | -2.82% | JP Morgan | $38.5 → $50 | Maintains | Neutral |
| 07/29/2020 | 18.56% | Evercore ISI Group | → $61 | Upgrades | In-Line → Outperform |
| 06/05/2020 | -28.09% | Evercore ISI Group | → $37 | Downgrades | Outperform → In-Line |
| 04/09/2020 | -31.97% | Raymond James | $52 → $35 | Reiterates | → Strong Buy |
| 03/18/2020 | -57.24% | JP Morgan | $46.5 → $22 | Maintains | Neutral |
| 01/31/2020 | 1.07% | Raymond James | $49 → $52 | Maintains | Strong Buy |
| 01/31/2020 | -18.37% | Wells Fargo | $39 → $42 | Downgrades | Equal-Weight → Underweight |
| 09/13/2019 | -20.31% | Wedbush | $35 → $41 | Maintains | Neutral |
| 09/13/2019 | -4.76% | Raymond James | $42 → $49 | Upgrades | Outperform → Strong Buy |
| 08/01/2019 | -31.97% | Wedbush | $30 → $35 | Reiterates | → Neutral |
| 11/12/2018 | -37.8% | Wedbush | $31 → $32 | Maintains | Neutral |
| 11/02/2018 | -39.75% | Wedbush | $34 → $31 | Maintains | Neutral |
| 10/25/2018 | -39.75% | Evercore ISI Group | $33 → $31 | Upgrades | In-Line → Outperform |
| 09/21/2018 | -37.8% | JP Morgan | $38 → $32 | Downgrades | Neutral → Underweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 08/03/2023 | 16.62% | 雷蒙德·詹姆斯 | $55→$60 | 維護 | 跑贏大盤 |
| 07/31/2023 | -0.87% | 韋德布什 | $28→$51 | 維護 | 中性 |
| 07/14/2023 | 6.9% | 雷蒙德·詹姆斯 | →$55 | 升級 | 市場表現優於→ |
| 2023/06/14 | - | 環球海港 | 開始承保 | →中性 | |
| 05/03/2023 | -45.58% | 韋德布什 | →$28 | 重申 | →中性 |
| 03/06/2023 | -46.55% | 摩根大通 | $30.5→$27.5 | 維護 | 體重不足 |
| 2022年11月22日 | -45.58% | 摩根大通 | $27→$28 | 評級下調 | 中性→減持 |
| 11/03/2022 | -47.52% | 摩根大通 | $31.5→$27 | 維護 | 中性 |
| 2022年10月21日 | - | 雷蒙德·詹姆斯 | 評級下調 | 強勁的購買→市場表現 | |
| 08/01/2022 | -14.48% | 雷蒙德·詹姆斯 | $77→$44 | 維護 | 強勢購買 |
| 07/12/2022 | -26.14% | 摩根大通 | $40.5→$38 | 維護 | 中性 |
| 06/17/2022 | -47.52% | 富國銀行 | →$27 | 評級下調 | 等重→減碼 |
| 04/13/2022 | -24.2% | 摩根大通 | $49→$39 | 維護 | 中性 |
| 03/10/2022 | -4.76% | 摩根大通 | $66→$49 | 維護 | 中性 |
| 11/08/2021 | 49.66% | 雷蒙德·詹姆斯 | $79→$77 | 維護 | 強勢購買 |
| 10/14/2021 | 28.28% | 摩根大通 | →$66 | 評級下調 | 超重→中性 |
| 2021/08/19 | 53.55% | 雷蒙德·詹姆斯 | $80→$79 | 維護 | 強勢購買 |
| 04/16/2021 | 26.34% | 富國銀行 | →$65 | 開始承保 | →等重 |
| 03/16/2021 | - | 沃爾夫研究 | 開始承保 | →對等性能 | |
| 03/12/2021 | 22.45% | B of A證券 | →$63 | 評級下調 | 中性→表現不佳 |
| 02/02/2021 | 百分之三十八 | 雷蒙德·詹姆斯 | $71→$71 | 維護 | 強勢購買 |
| 2021/01/25 | 百分之三十八 | 雷蒙德·詹姆斯 | $61→$71 | 維護 | 強勢購買 |
| 01/05/2021 | - | B of A證券 | 評級下調 | 購買→中性 | |
| 10/30/2020 | -10.59% | 富國銀行 | →$46 | 升級 | 重量不足的→等重 |
| 10/08/2020 | 30.22% | 摩根大通 | →$67 | 升級 | 中性→超重 |
| 2020/09/15 | 10.79% | B of A證券 | →$57 | 升級 | 中性→購買 |
| 07/29/2020 | -2.82% | 摩根大通 | $38.5→$50 | 維護 | 中性 |
| 07/29/2020 | 18.56% | Evercore ISI集團 | →$61 | 升級 | 線內→表現優異 |
| 06/05/2020 | -28.09% | Evercore ISI集團 | →$37 | 評級下調 | 勝過→同線 |
| 04/09/2020 | -31.97% | 雷蒙德·詹姆斯 | $52→$35 | 重申 | →強勢購買 |
| 03/18/2020 | -57.24% | 摩根大通 | $46.5→$22 | 維護 | 中性 |
| 2020/01/31 | 1.07% | 雷蒙德·詹姆斯 | $49→$52 | 維護 | 強勢購買 |
| 2020/01/31 | -18.37% | 富國銀行 | $39→$42 | 評級下調 | 等重→減碼 |
| 2019年09月13日 | -20.31% | 韋德布什 | $35→$41 | 維護 | 中性 |
| 2019年09月13日 | -4.76% | 雷蒙德·詹姆斯 | $42→$49 | 升級 | 跑贏→強勢買入 |
| 2019年08月01日 | -31.97% | 韋德布什 | $30→$35 | 重申 | →中性 |
| 2018年11月12日 | -37.8% | 韋德布什 | $31→$32 | 維護 | 中性 |
| 11/02/2018 | -39.75% | 韋德布什 | $34→$31 | 維護 | 中性 |
| 2018年10月25日 | -39.75% | Evercore ISI集團 | $33→$31 | 升級 | 線內→表現優異 |
| 2018年09月21日 | -37.8% | 摩根大通 | $38→$32 | 評級下調 | 中性→減持 |
What is the target price for M.D.C. Holdings (MDC)?
M.D.C.Holdings(MDC)的目標價是多少？
The latest price target for M.D.C. Holdings (NYSE: MDC) was reported by Raymond James on August 3, 2023. The analyst firm set a price target for $60.00 expecting MDC to rise to within 12 months (a possible 16.62% upside). 9 analyst firms have reported ratings in the last year.
M.D.C.Holdings(紐約證券交易所代碼：MDC)的最新目標價是由Raymond James於2023年8月3日報道的。這家分析公司將目標價定為60.00美元，預計MDC將在12個月內上漲至16.62%(可能上漲16.62%)。去年有9家分析公司公佈了評級。
What is the most recent analyst rating for M.D.C. Holdings (MDC)?
分析師對M.D.C.Holdings(MDC)的最新評級是多少？
The latest analyst rating for M.D.C. Holdings (NYSE: MDC) was provided by Raymond James, and M.D.C. Holdings maintained their outperform rating.
M.D.C.Holdings(紐約證券交易所代碼：MDC)的最新分析師評級由Raymond James提供，M.D.C.Holdings維持其表現優於大盤的評級。
When is the next analyst rating going to be posted or updated for M.D.C. Holdings (MDC)?
M.D.C.Holdings(MDC)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of M.D.C. Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for M.D.C. Holdings was filed on August 3, 2023 so you should expect the next rating to be made available sometime around August 3, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公開的財務報表，與M.D.C.Holdings的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。M.D.C.Holdings的上一次評級是在2023年8月3日提交的，所以你應該預計下一次評級將在2024年8月3日左右的某個時候公佈。
Is the Analyst Rating M.D.C. Holdings (MDC) correct?
分析師對M.D.C.Holdings(MDC)的評級正確嗎？
While ratings are subjective and will change, the latest M.D.C. Holdings (MDC) rating was a maintained with a price target of $55.00 to $60.00. The current price M.D.C. Holdings (MDC) is trading at is $51.45, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但M.D.C.Holdings(MDC)的最新評級維持不變，目標價在55.00美元至60.00美元之間。M.D.C.Holdings(MDC)目前的股價為51.45美元，超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。